However, the incidence of MEK1 or MEK2 gene mutation is higher in CFC syndrome (about 25% of all CFC cases) than in the other RASopathies14, suggesting that these germline MEK mutations are not necessarily related to cancer development. The gene discussed is MAP2K7; the disease is cardiofaciocutaneous syndrome.